Genesis IBRC
89.42
-4.70(-4.99%)
Market Cap₹116.29 Cr
PE Ratio-522.89
IndustryHealthcare
Company Performance:
1D-4.99%
1M+10.89%
6M+185.60%
1Y+387.57%
5Y+1,098.66%
View Company Insightsright
More news about Genesis IBRC
10Jan 26
V Varalakshmi Acquires 7.37 Lakh Shares in Genesis IBRC India Limited, Promoter Group Holding Rises to 74.17%
V Varalakshmi has acquired 7,36,500 equity shares in Genesis IBRC India Limited through an off-market transaction on January 7, 2026, increasing her stake from 55.92% to 61.58%. Padmanaban Krishnamoorthy, acting in concert, also acquired an equal number of shares, raising his holding from 6.92% to 12.59%. The combined promoter group holding has increased to 74.17% from 62.84%, representing a significant consolidation of control in the BSE-listed company.
 no imag found
10Jan 26
Genesis IBRC India Limited Reports Substantial Acquisition of 14.73 Lakh Shares by Promoter Group
Genesis IBRC India Limited disclosed a substantial acquisition by promoter group members Padmanaban Krishnamoorthy and V Varalakshmi, who acquired 14,73,000 equity shares through off-market transaction on January 7, 2026. The acquisition increased their combined shareholding from 62.84% to 74.17% of the company's total share capital. The transaction was executed via Share Purchase Agreement with transfers completed on January 7-8, 2026, and disclosed under SEBI regulations on January 9, 2026.
 no imag found
09Jan 26
Genesis IBRC India Promoters Complete Off-Market Sale of 11.33% Equity Stake
Genesis IBRC India Limited promoters completed an off-market sale of 14,73,000 equity shares (11.33% stake) to two new acquirers on January 7-8, 2026. Four promoters transferred their complete shareholding to Mr. Venkatraman Varalakshmi and Mr. Padmanaban Krishnamoorthy through an off-market transaction. The company's equity capital structure remains unchanged at ₹13.00 crores comprising 1.30 crore shares of ₹10 each.
 no imag found
08Jan 26
Genesis IBRC India Limited Announces Complete Promoter Exit Through Share Transfer
Genesis IBRC India Limited has completed a major ownership restructuring with existing promoters transferring their entire 14.73 lakh shareholding to new acquirers through an off-market transfer on January 8, 2026. The transaction, governed by a Share Purchase Agreement from March 6, 2025, involves the complete exit of four existing promoters and triggers their reclassification from promoter category to public category under SEBI regulations.
 no imag found
31Dec 25
Genesis IBRC India Limited Announces Resignation of Company Secretary Ramakrishna Subray Hegde
Genesis IBRC India Limited announced the resignation of Company Secretary and Compliance Officer Mr. Ramakrishna Subray Hegde, effective December 31, 2025, due to personal reasons. Whole-time Director Mr. Balakrishna Koppula will serve as interim Compliance Officer until a replacement is appointed. The company has completed all required regulatory disclosures under SEBI LODR Regulations to BSE Limited.
 no imag found
22Nov 25
Genesis IBRC India: Open Offer Completed, Combined Stake Reaches 62.84%
Genesis IBRC India Limited has successfully completed its open offer process, with Mr. Padmanaban Krishnamoorthy acquiring 9,00,200 shares representing 6.92% of voting capital at ₹27 per share. This acquisition, combined with Ms. V Varalakshmi's existing shareholding of 72,69,500 shares (55.92%), brings their total combined stake to 81,69,700 shares or 62.84% of the company's voting capital, as disclosed under SEBI Regulation 29.
 no imag found
Genesis IBRC
89.42
-4.70
(-4.99%)
1 Year Returns:+387.57%
Industry Peers
Anthem Biosciences
605.30
(-0.35%)
Advanced Enzyme Tech
291.85
(+2.15%)
Genesis IBRC
89.42
(-4.99%)
Vivo Bio Tech
29.00
(-1.02%)